Sidoti Csr Analysts Boost Earnings Estimates for USNA

USANA Health Sciences, Inc. (NYSE:USNA) – Stock analysts at Sidoti Csr increased their Q1 2025 earnings estimates for USANA Health Sciences in a research report issued to clients and investors on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now anticipates that the company will post earnings per share of $0.84 for the quarter, up from their previous estimate of $0.73. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences’ Q2 2025 earnings at $0.74 EPS, Q3 2025 earnings at $0.73 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $3.09 EPS and FY2026 earnings at $3.63 EPS.

USNA has been the topic of a number of other reports. DA Davidson raised USANA Health Sciences to a “hold” rating in a research note on Friday, December 20th. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Thursday, December 19th.

USANA Health Sciences Trading Down 2.0 %

Shares of USNA opened at $35.94 on Friday. The firm’s fifty day simple moving average is $37.88 and its two-hundred day simple moving average is $40.01. USANA Health Sciences has a 12 month low of $31.44 and a 12 month high of $54.81. The stock has a market capitalization of $685.02 million, a P/E ratio of 12.70, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. During the same quarter in the prior year, the firm posted $0.59 EPS.

Institutional Investors Weigh In On USANA Health Sciences

Hedge funds and other institutional investors have recently modified their holdings of the company. Bank of New York Mellon Corp increased its stake in USANA Health Sciences by 5.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 97,375 shares of the company’s stock valued at $4,405,000 after purchasing an additional 5,205 shares in the last quarter. Panagora Asset Management Inc. grew its holdings in shares of USANA Health Sciences by 143.1% during the second quarter. Panagora Asset Management Inc. now owns 28,881 shares of the company’s stock valued at $1,307,000 after buying an additional 16,999 shares during the last quarter. Rhumbline Advisers increased its position in shares of USANA Health Sciences by 7.1% during the second quarter. Rhumbline Advisers now owns 36,486 shares of the company’s stock worth $1,651,000 after acquiring an additional 2,425 shares in the last quarter. Pzena Investment Management LLC raised its holdings in shares of USANA Health Sciences by 24.4% in the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock worth $44,183,000 after acquiring an additional 191,289 shares during the last quarter. Finally, TD Asset Management Inc lifted its position in USANA Health Sciences by 26.4% in the 2nd quarter. TD Asset Management Inc now owns 11,500 shares of the company’s stock valued at $520,000 after acquiring an additional 2,400 shares in the last quarter. Institutional investors own 54.25% of the company’s stock.

Insiders Place Their Bets

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.33% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.